<DOC>
	<DOCNO>NCT02866877</DOCNO>
	<brief_summary>This study evaluate pharmacokinetic profile levetiracetam critically ill patient suffer subarachnoid hemorrhage . The patient evaluate development augment renal clearance effect duration effect may levetiracetam clearance .</brief_summary>
	<brief_title>Effects Augmented Renal Clearance Pharmacokinetic Pharmacodynamic Properties Levetiracetam Subarachnoid Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<criteria>Patients diagnose nontraumatic subarachnoid hemorrhage require levetiracetam seizure prophylaxis treatment Presentation University Colorado Hospital within 48 hour subarachnoid hemorrhage Adults age 18 89 year Anticipated length stay ≥ 48 hour Informed consent provide patient patient 's designated medical proxy Pregnancy Patients receive renal replacement therapy Brain death imminent brain death expect ≤48 hour Patient history nephrectomy renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>augment renal clearance</keyword>
</DOC>